Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Pramiconazole: Phase IIa data

In an ongoing, open-label Phase IIa trial in 18 evaluable patients,

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE